Keywords: amgen, sees, whopping, net, profit, sales, rises
Amgen sees whopping 38% net profit and 26% sales rises, beating all expectations
Article | 01 August 2005
Amgen, the world's largest biotechnology company, saw its share price surge 15% to $81.17 after it reported record-breaking and better-than-expected second-quarter 2005 results.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
